Pharmaceutical Technology

MAY 15, 2023

The company works towards improving patient and physician experiences through the development, acquisition and commercialisation of innovative aesthetic and therapeutic offerings. Revance Therapeutics is a biotechnology company that focuses on the development, manufacturing, and marketing of novel botulinum toxin products.

Leads 52

Leads Pharmaceutical Physicians Food 52

Clarivate

MAY 24, 2022

In May 2010, the Chinese Medical Association (CMA) reached an expert consensus that defined rare diseases as those with a prevalence of less than 1 in 500,000, or with a morbidity rate of less than 1 in 10,000, among newborns. [2] Multinational pharmas seek entry for their products. Establishing a definition of rare disease.

Patients 52

Patients Food and Drug Administration Marketing Pharma 52

Pharmaceutical Technology

OCTOBER 5, 2008

But the recent acquisition by Japanese pharmaceutical provider Shionogi of US-based rival Sciele Pharma, worth $1,276m, is just the latest in a spree of big and bold outbound deals. However, BMI forecasts that the market share for these low-cost products in Japan will double by 2010, adding almost $5bn in value to the sector.”

Government 52

Government Marketing Pharmaceutical Physicians 52

PM360

NOVEMBER 29, 2022

1 And, on average , the FDA approved 60% more drugs between 2010-2019 than the yearly average over the previous decade. NSF, “Pharma Pipeline at an All-Time High,” from Informa Pharma R&D Annual Review 2022 (May 2022). Reference: 1. See resource here.

Medical science 95

Medical science Medical Customer Relationship Management Doctors 95

Evolve Your Success

OCTOBER 18, 2022

I’m sure that you are in the biotech pharma world making good money and your ego was like, “Stay here and make money,” but your intuition was like, “No. The idea of trying to sell and influence hospitals and physicians using social media was a joke, but the data said otherwise. It encompasses biotech, pharma, dental and diagnostic.

Marketing 52

Marketing Sales Medical sales Medical 52

Pharmaceutical Technology

OCTOBER 25, 2022

More FDC products flowing into pharma pipelines. Between 2010 and the end of 2015, of the 655 New Drug Applications (NDAs) approved by the FDA, 63 were for FDCs. Among the numerous advantages FDCs offer patients, physicians, and pharmaceutical companies, several are particularly noteworthy. The numbers tell the story.

Manufacturing 52

Manufacturing Physicians Prescription FDA 52

PM360

JUNE 11, 2022

Qualitative and quantitative research help pharma brand teams understand physician and patient attitudes, behaviors, and perspectives. For example, consider a pharma brand team trying to market its newest triple inhaler therapy for the treatment of COPD against its top competitor. Seize the Initiative.

Marketing 52

Marketing Competition Pharma Manufacturing 52

Evolve Your Success

MAY 16, 2023

It’s organizations like Medasic that are a group of physicians and nurses that have their hearts in the right place that are trying to help patients get off of these drugs and have a better life. I remember back in my pharmaceutical sales rep days and I’m talking as far as 2009 or 2010. It blew back in the pharma companies.

Medical sales 52

Medical sales Sales Medical Doctors 52

Pharmaceutical Technology

DECEMBER 4, 2022

Others are made by big pharma giants like Boehringer Ingelheim , Novartis , or Pfizer , which has raised the expectations for a competitive market. . Even some physicians remain hesitant about biosimilars in general. There are seven FDA-approved Humira biosimilars, of which Amgen’s Amjevita will be launched in January.

Marketing 104

Marketing Physicians Competition Patients 104